Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
about
Imaging radiation response in tumor and normal tissue.Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients.Pathophysiology, diagnosis, and treatment of radiation necrosis in the brainAdvanced MR imaging of gliomas: an updateCharacterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Response criteria for glioma.MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast.Texture Descriptors to distinguish Radiation Necrosis from Recurrent Brain Tumors on multi-parametric MRI.Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma.Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapyNeuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasmsDifferentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging.The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.Comparison between MR Perfusion and 18F-FDG PET in Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing TissueLong-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imagingBevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.Mechanisms of radiation toxicity in transformed and non-transformed cellsComputer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility StudyCombined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma paDifferentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients - A Review.Differential diagnosis of a vanishing brain space occupying lesion in a child.Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastomaMultiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma.Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatmentDevelopment of a novel animal model to differentiate radiation necrosis from tumor recurrence.Radiation necrosis masquerading as late tumor recurrence: 14 years after combined fractionated stereotactic radiosurgery and conventional radiation therapy.Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation.The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence.Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants.Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.
P2860
Q26798266-9ED10AB3-59C0-442B-B053-90CA3BF4B557Q27342287-1CEE6D40-1051-4996-8C1F-00CBAF88589BQ28083668-C71D1246-E878-445C-8EAD-CDDEE5274A37Q30655700-F42931E2-E942-46D0-93EE-CDEACA7C9B84Q30937034-E240B2CB-8E94-4186-8BD0-1FED7441BFEBQ31172444-75A64A67-AAB4-44BC-995E-475F3FC230AFQ33534946-F54383BE-3AF8-4C82-BB1D-D955A92E3C54Q33711485-8F4B0872-4135-4FFF-9A1A-E307E62C8F8DQ33916064-8A31F968-5DB4-4FD2-91BA-E3E24F28C2A8Q34139432-717A35AF-3BEA-4A1E-A4EC-0B23C31D87F7Q34280336-66CCDF86-D8BA-4D98-A382-481FDBC0A001Q34369465-CF6A7692-1C77-4ECF-B6F1-789F317596BFQ34681190-09A31FEC-743C-407D-B80C-267DD80FF29CQ35170356-D718AAC3-C33C-49D7-A834-8F3E20B67062Q35713015-932035B9-C04F-455D-B97D-3536A0D1A520Q36107374-6233338B-CDC4-4BCA-97B1-C65F7A24DD50Q36356127-57BFC56E-95C5-40D1-ADD7-A94F3BA69196Q36501587-0FFBF10A-9F4D-4AE8-8FB4-AEAC6AA5C806Q36893250-9489D179-1D77-493D-B9BE-43E62C5BC6F4Q36953470-0B94D730-65B9-41A8-8089-B49B152C2D62Q37109256-B9778E19-7A52-4557-9337-211F0904EC31Q37139115-839559DB-1983-4513-9005-16562318B750Q37510595-33D355A7-F4FE-4512-BE4E-6F7F308A0E93Q37746319-1FBD5675-FBAC-4E29-BBE6-5CBB8A3524BDQ38074638-37B952E5-375A-4B88-8A02-BAC3322A09F0Q38102999-16FC0A45-BD6F-4DBA-AF80-F2A04949E5B8Q39180368-A2CD64FC-38AA-4076-B43E-0A0647AC82D5Q40882104-8D1A76C3-12A3-455C-8838-7F13C382839BQ41462863-19BC4A1C-9258-402E-8989-BF4FD072BB7DQ41654869-F2764AEB-00A0-4727-A14A-C6BF1D8768DDQ41770425-EDA3AA66-1E78-43E6-A8D5-0B666DD22464Q41839918-E701AF70-EE70-4DC0-80EC-CF86BF887B5EQ41845711-DDD1752A-384D-419F-85D3-FFF0300A65BFQ47114149-B2ADD681-87E3-490E-8FFB-095C17EAD5F2Q47825877-9C255F49-BFDF-43C6-B14C-8A7C44E7ED97Q47911695-7396BF79-E644-4F75-92BE-8653A28F3CF2Q52681027-3ED2AD71-0935-46BD-9B48-E6A41F6C207F
P2860
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@en
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@nl
type
label
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@en
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@nl
prefLabel
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@en
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
@nl
P2093
P1476
Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis
@en
P2093
Fred H Hochberg
Glenn D Barest
Mark E Mullins
Michael H Lev
Pamela W Schaefer
R Gilberto Gonzalez
P304
P577
2005-09-01T00:00:00Z